Banner - Collaborative Care Symposium
News
All NewsContributorsMoney Matters
Media
All VideosExpert InterviewsMedical World NewsPodcastsBeyond The WallsCase Based Roundtable SeriesCase of the QuarterEyeViewGrand RoundsInsightsRapid ReadoutSpecial ReportViewpointsWhat’s Your WhEYE?
Conferences
Conference CoverageConference Listing
Events
More
Publications
Digital EditionEurope Ophthalmology TimesModern RetinaSupplements and Featured Publications
CME
Partners
Resources
Job BoardSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publications
  • CME
  • Partners
  • Subscribe
  • Resources
  • AMD
  • Biosimilars
  • COVID-19
  • Cataract
    • Cataract Surgery
  • Cataract Therapeutics
  • Clinical Diagnosis
    • The Residency Report
    • iOpeners
    • NeuroOp Guru
  • Cornea
  • DME
  • Dry Eye
    • Dry Eye Awareness
  • Gene Therapy
  • Geographic Atrophy
  • IOL
    • IOL Advances
  • Imaging
  • Interventional Glaucoma
    • Glaucoma Awareness
    • Glaucoma Insights
    • Therapeutic Glaucoma
  • OCT
  • Ocular Allergy
  • Ocular Surface Disease
  • Optic Relief
  • Optometry
  • Pediatrics
  • Pharmacy
  • Practice Management
    • Indispensable
  • Presbyopia
  • Ptosis
  • Refractive
    • Refractive Surgery
  • Retina
  • Surgery
  • Technology
  • Therapeutics
  • Understanding Antibiotic Resistance
  • Workplace
Spotlight -
Retina
Advertisement

Ophthalmology Times: Feb. 1, 2020

Expert on IFIS offers practical pearls for success

ByCheryl Guttman Krader, BS, Pharm
February 22nd 2021

Cataract surgeons must consider medication history as part of preoperative evaluation.

Studies target unilateral gene therapy injection

ByLynda Charters
January 28th 2020
Performing cataract surgery on a patient

Improving outcomes of cataract surgery

ByCheryl Guttman Krader, BS, Pharm
January 27th 2020
Optic nerve head OD shown in an OCT indicates glaucoma progression

OCT artifacts and pitfalls: In the eye of the beholder

ByLynda Charters
January 26th 2020
Advertisement
Advertisement

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

1

First patient treated in ViaLase’s IDE trial

2

Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD

3

Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007

4

Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA

5

PainReform launches development plan for OcuRing-K, readies phase 2 trial

  • About
  • Advertise
  • Privacy
  • Editorial Info
  • Editorial Board
  • Terms and Conditions
  • Contact Us
  • Do Not Sell My Personal Information
  • Job Board
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
EyeCare Network
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us